| Literature DB >> 33847802 |
Theresa E Gross1,2, Jan Fleckhaus1, Peter M Schneider3.
Abstract
A European-wide online survey was conducted to generate an overview on the state-of-the-art using massively parallel sequencing (MPS) platforms for forensic DNA analysis and DNA phenotyping among forensic practitioners in Europe. The survey was part of the dissemination activities of the "VISible Attributes through GEnomics - VISAGE" Horizon 2020 funded European research project [30], in preparation of a series of educational training activities. A total of 105 replies from 32 European countries representing participants from police, governmental, academic, and private laboratories providing professional services in the field of forensic genetics were included in the final analysis. Of these, 73% already own an MPS platform or are planning to acquire one within the next 1-2 years. One-third of the participants have already carried out MPS-based STR sequencing, identity, or ancestry SNP typing. A total of 23-40% of participants are planning to explore all FDP applications showing the overall very high interest in using MPS for the whole range of forensic MPS markers and applications. About 50% of the participants have previously gathered experience using forensic DNA phenotyping (FDP) markers based on conventional (i.e., not MPS-based) DNA typing methods. A total of 55% of the participants have attended training on the general use of MPS technology, but 36% have received no training whatsoever. Accordingly, 90% have expressed high or medium interest to attend training on the analysis and interpretation of DNA phenotyping data for predicting appearance, ancestry, and age. The results of our survey will provide valuable information for organizing relevant training workshops on all aspects of MPS-based DNA phenotyping for the forensic genetics scientific community.Entities:
Keywords: DNA phenotyping; Forensic DNA casework; Next-generation sequencing; Online survey
Mesh:
Year: 2021 PMID: 33847802 PMCID: PMC8205868 DOI: 10.1007/s00414-021-02569-0
Source DB: PubMed Journal: Int J Legal Med ISSN: 0937-9827 Impact factor: 2.686
European survey participants by numbers and percentages
| Country | Sample | Percent |
|---|---|---|
| Albania | 1 | 1.0% |
| Austria | 2 | 1.9% |
| Belgium | 4 | 3.8% |
| Bosnia and Herzegovina | 1 | 1.0% |
| Croatia | 2 | 1.9% |
| Czech Republic | 3 | 2.9% |
| Denmark | 1 | 1.0% |
| Estonia | 1 | 1.0% |
| Finland | 1 | 1.0% |
| France | 4 | 3.8% |
| Germany | 30 | 28.6% |
| Greece | 4 | 3.8% |
| Hungary | 1 | 1.0% |
| Ireland | 1 | 1.0% |
| Italy | 9 | 8.6% |
| Latvia | 2 | 1.9% |
| Lithuania | 1 | 1.0% |
| Luxembourg | 1 | 1.0% |
| Macedonia | 2 | 1.9% |
| Montenegro | 1 | 1.0% |
| Netherlands | 4 | 3.8% |
| Norway | 2 | 1.9% |
| Poland | 4 | 3.8% |
| Portugal | 2 | 1.9% |
| Romania | 3 | 2.9% |
| Serbia | 1 | 1.0% |
| Slovakia | 1 | 1.0% |
| Slovenia | 1 | 1.0% |
| Spain | 7 | 6.7% |
| Sweden | 1 | 1.0% |
| Switzerland | 4 | 3.8% |
| UK | 3 | 2.9% |
Composition of survey participants and previous experience with MPS platforms
| ENFSI member | MPS ownership | Planned purchase within | No plans | Type of instrument | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Type of laboratory | Yes | No | > 2 years | < 2 years | 12 months | 1–2 years | MiSeq | Ion PGM | Other | |
| MiSeqFGx | Ion S5 | |||||||||
| Police/governmental | 37 | 6 | 14 | 5 | 2 | 12 | 10 | 12 | 10 | |
| Academic | 9 | 32 | 17 | 6 | 2 | 6 | 10 | 13 | 18 | 3 |
| Private | 1 | 17 | 3 | 1 | 1 | 5 | 8 | 3 | 2 | |
| Other | 1 | 2 | 2 | 1 | 2 | 1 | ||||
| Total | 48 | 57 | 34 | 14 | 5 | 23 | 29 | 30 | 30 | 4 |
Breakdown of MPS-based forensic genomic applications according to their organizational structure
| Type of laboratory | Already done/planned to do | MPS-based forensic application | ||||||
|---|---|---|---|---|---|---|---|---|
| (No. of labs) | STR analysis | mtDNA | Identity SNPs | Ancestry SNPs | Appearance SNPs | Methylation analysis | mRNA analysis | |
| Police/governmental | Yes | 14 | 9 | 12 | 11 | 11 | 4 | 3 |
| ( | Planned | 18 | 12 | 20 | 16 | 19 | 21 | 15 |
| Academic | Yes | 13 | 9 | 13 | 14 | 10 | 8 | 7 |
| ( | Planned | 16 | 13 | 12 | 11 | 14 | 18 | 10 |
| Private | Yes | 5 | 2 | 4 | 2 | 1 | 2 | 1 |
| ( | Planned | 5 | 6 | 6 | 6 | 6 | 3 | 2 |
| Other | Yes | 2 | 0 | 2 | 1 | 1 | 1 | 1 |
| ( | Planned | 0 | 2 | 0 | 1 | 0 | 0 | 0 |